Article info
Systemic lupus erythematosus
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
- Correspondence to Dr Yong Yuan; yuany{at}zsph.com
Citation
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Publication history
- Received March 18, 2024
- Accepted May 8, 2024
- First published May 22, 2024.
Online issue publication
September 30, 2024
Article Versions
- Previous version (22 May 2024).
- Previous version (30 May 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ on behalf of EULAR.